Greenleaf Trust’s Darling Ingredients DAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$365K Buy
6,682
+3
+0% +$179 ﹤0.01% 608
2026
Q1
$413K Sell
6,679
-254
-4% -$12.5K ﹤0.01% 537
2025
Q4
$250K Sell
6,933
-239
-3% -$8.09K ﹤0.01% 717
2025
Q3
$221K Buy
7,172
+997
+16% +$33.3K ﹤0.01% 747
2025
Q2
$234K Buy
+6,175
New +$203K ﹤0.01% 716
2023
Q3
Sell
-3,752
Closed -$239K 751
2023
Q2
$239K Sell
3,752
-284
-7% -$17.3K ﹤0.01% 670
2023
Q1
$236K Buy
4,036
+91
+2% +$5.72K ﹤0.01% 680
2022
Q4
$247K Sell
3,945
-198
-5% -$14K ﹤0.01% 649
2022
Q3
$274K Sell
4,143
-495
-11% -$34.5K ﹤0.01% 569
2022
Q2
$277K Sell
4,638
-835
-15% -$63.4K ﹤0.01% 573
2022
Q1
$440K Sell
5,473
-41
-0.7% -$2.86K 0.01% 460
2021
Q4
$382K Buy
5,514
+2,054
+59% +$149K ﹤0.01% 518
2021
Q3
$249K Buy
3,460
+365
+12% +$26.1K ﹤0.01% 634
2021
Q2
$209K Buy
3,095
+31
+1% +$2.18K ﹤0.01% 694
2021
Q1
$225K Buy
+3,064
New +$211K ﹤0.01% 652

Other funds holding DAR

Greenleaf Trust's DAR Position: Q2 2026 in Review

Greenleaf Trust increased its Darling Ingredients (DAR) stake by 0.04% in Q2 2026, buying an estimated $179 and bringing the position to 6,682 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #608.

Greenleaf Trust first reported a position in DAR in Q1 2021 and has held it in 15 quarters since. The position peaked at $440K in Q1 2022. 615 funds tracked by Wall St. Rank hold DAR as of Q2 2026.

  • Greenleaf Trust held 6,682 shares of Darling Ingredients worth $365K as of Q2 2026.
  • Greenleaf Trust bought 3 Darling Ingredients shares in Q2 2026, an estimated $179.
  • Darling Ingredients made up ﹤0.01% of Greenleaf Trust's portfolio in Q2 2026, its #608 holding.
  • Greenleaf Trust first reported a position in Darling Ingredients in Q1 2021 and has held it in 15 quarters since.
  • Greenleaf Trust's Darling Ingredients position peaked at $440K in Q1 2022.
  • 615 funds tracked by Wall St. Rank held Darling Ingredients as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.